Market Capitalization (Millions $) |
129 |
Shares
Outstanding (Millions) |
82 |
Employees |
- |
Revenues (TTM) (Millions $) |
4 |
Net Income (TTM) (Millions $) |
-142 |
Cash Flow (TTM) (Millions $) |
-16 |
Capital Exp. (TTM) (Millions $) |
1 |
Ngm Biopharmaceuticals Inc
NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on developing transformative therapeutics for serious diseases. The company utilizes its expertise in biology, chemistry, and immunology to discover and develop novel therapies.
NGM Biopharmaceuticals is known for its innovative approach to drug discovery, using cutting-edge technology and advanced research techniques to identify targets and potential therapeutic candidates. The company's pipeline includes therapies for several indications, including liver diseases, ophthalmology, and cancer.
NGM Biopharmaceuticals has a strong commitment to improving patient outcomes and addressing unmet medical needs. The company's mission is to develop safe and effective therapies that make a meaningful impact on patients' lives.
Overall, NGM Biopharmaceuticals Inc is a dynamic biopharmaceutical company with a robust pipeline and a focus on innovative drug discovery to address critical diseases.
Company Address: 333 Oyster Point Boulevard South San Francisco 94080 CA
Company Phone Number: 243-5555 Stock Exchange / Ticker: NASDAQ NGM
|